This scoping review was designed to synthesize the extant literature on associations
between subjective and/or objective measures of cancer-related cognitive impairment …

Background This systematic review and meta‐analysis aim to synthesize the available
evidence and determine the overall brain‐derived neurotrophic factor (BDNF) levels in …

Brain-derived neurotrophic factor (BDNF) improves cognitive function by stimulating
neurogenesis and neuroplasticity. We hypothesize that higher plasma BDNF levels are …

Cancer-related cognitive impairment (CRCI) considerably affects the quality of life of millions
of cancer survivors. Brain-derived neurotrophic factor (BDNF) has been shown to promote …

Abstract Dynamin-1 (DNM1) is crucial for synaptic activity, neurotransmission, and
associative memory, positioning it as a potential biomarker of cancer-related cognitive …

Cranial radiation therapy (RT) for brain cancers is often associated with the development of
radiation-induced cognitive dysfunction (RICD). RICD significantly impacts the quality of life …

Cancer-related cognitive impairment (CRCI) has increasingly been identified over the last
two decades in non-CNS system cancer patients. Across Europe, researchers have …

Background Breast cancer survivors (BCS) often complain of cancer‐related cognitive
impairment (CRCI) during and even months after completing primary cancer treatments …

Objective: To explore the clinical efficacy of individualized health education (IHE) and care
mode based on magnetic resonance imaging (MRI) combined with Mini-Mental State …

Cancer-related cognitive impairments (CRCI) are neurological complications associated
with cancer treatment, and greatly affect cancer survivors' quality of life. Brain-derived …